ARCA biopharma, Inc.

ARCA biopharma, Inc.verified

ABIO

Price:

$28.8

Market Cap:

$1.13B

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial; and research collaboration with Colorad...[Read more]

Industry

Biotechnology

IPO Date

1997-08-08

Stock Exchange

NASDAQ

Ticker

ABIO

The Enterprise Value as of December 2025 (TTM) for ARCA biopharma, Inc. (ABIO) is 1.04B

According to ARCA biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.04B. This represents a change of 134.30% compared to the average of 444.59M of the last 4 quarters.

ARCA biopharma, Inc. (ABIO) Historical Enterprise Value (quarterly & annually)

How has ABIO Enterprise Value performed in the past?

The mean historical Enterprise Value of ARCA biopharma, Inc. over the last ten years is 138.49M. The current 1.04B Enterprise Value has changed 75.11% with respect to the historical average. Over the past ten years (40 quarters), ABIO's Enterprise Value was at its highest in in the September 2025 quarter at 758.07M. The Enterprise Value was at its lowest in in the September 2024 quarter at -41902315.95.

Quarterly (TTM)
Annual

Average

138.49M

Median

98.24M

Minimum

-9556885.20

Maximum

367.76M

ARCA biopharma, Inc. (ABIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ARCA biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.79%

Maximum Annual Enterprise Value = 367.76M

Minimum Annual Increase = -22527.96%

Minimum Annual Enterprise Value = -9556885.20

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024264.94M3.12%
2023256.93M-30.14%
2022367.76M20.25%
2021305.84M71.79%
2020178.04M-22527.96%
2019-793810.96-61.05%
2018-2037882.80-137.88%
20175.38M-70.82%
201618.44M-292.96%
2015-9556885.20-331.84%

ARCA biopharma, Inc. (ABIO) Average Enterprise Value

How has ABIO Enterprise Value performed in the past?

The current Enterprise Value of ARCA biopharma, Inc. (ABIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

296.54M

5-year avg

274.70M

10-year avg

138.49M

ARCA biopharma, Inc. (ABIO) Enterprise Value vs. Peers

How is ABIO’s Enterprise Value compared to its peers?

ARCA biopharma, Inc.’s Enterprise Value is greater than Grace Therapeutics, Inc. (30.42M), greater than LianBio (-41662245.00), greater than Satsuma Pharmaceuticals, Inc. (20.18M), greater than Lunai Bioworks Inc. (35.00M), greater than Opus Genetics, Inc. (129.57M), greater than Cerecor Inc. (-3660587.00), greater than Lumos Pharma, Inc. (24.19M), greater than Eyenovia, Inc. (38.86M), greater than Marinus Pharmaceuticals, Inc. (44.18M), greater than Angion Biomedica Corp. (14.84M),

CompanyEnterprise ValueMarket cap
30.42M$47.28M
-41662245.00$10.04M
20.18M$36.47M
35.00M$32.92M
129.57M$162.00M
-3660587.00$38.63M
24.19M$37.54M
38.86M$38.59M
44.18M$30.37M
14.84M$30.11M

Build a custom stock screener for ARCA biopharma, Inc. (ABIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARCA biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ARCA biopharma, Inc. (ABIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ARCA biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is ARCA biopharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for ARCA biopharma, Inc. (ABIO)?

What is the 3-year average Enterprise Value for ARCA biopharma, Inc. (ABIO)?

What is the 5-year average Enterprise Value for ARCA biopharma, Inc. (ABIO)?

How does the current Enterprise Value for ARCA biopharma, Inc. (ABIO) compare to its historical average?